Helping you make wiser investment decisions
Novo Nordisk adds bioelectronics, biosensors and stimuli-responsive delivery devices to scope of MIT pact ntaylor Tue, 03/15/2022 – 09:30 Source link
Playing catch-up with J&J, Sanofi taps Blackstone for $300M to fund pivotal trial of subcutaneous Sarclisa ntaylor Tue, 03/15/2022 – 09:04 Source link
Top Pfizer, Moderna execs at odds on need for 4th COVID-19 vaccine dose fkansteiner Tue, 03/15/2022 – 08:58 Source link
Incyte’s Opzelura slapped with vitiligo delay amid topical JAK’s eczema launch fkansteiner Mon, 03/14/2022 – 10:31 Source link
AstraZeneca’s Fasenra hit with FDA rejection, falling further behind GSK’s Nucala in nasal polyps aliu Mon, 03/14/2022 – 09:22 Source link
Pfizer pledges to donate all Russian profits to humanitarian causes amid war in Ukraine esagonowsky Mon, 03/14/2022 – 09:11 Source link
Novartis’ Sandoz bulks up in respiratory as strategic review of the generics outfit rolls on fkansteiner Mon, 03/14/2022 – 08:29 Source link
BeiGene, Hutchmed, Zai Lab tagged for potential US delisting under SEC audit rules, with more Chinese biotechs likely to face scrutiny aliu Fri, 03/11/2022 – 10:01 Source link
Amid inflation spike, execs at J&J, Bayer, GSK and more talk higher costs—and what it means for profits esagonowsky Fri, 03/11/2022 – 09:37 Source link
Moderna CEO Bancel set for a soft landing as his golden parachute swells to $926M kdunleavy Fri, 03/11/2022 – 09:25 Source link
Fierce Pharma Asia—Legend CEO’s cell therapy ambitions; Indian pharmas’ awkward position; new Hutchmed CEO aliu Fri, 03/11/2022 – 04:55 Source link
Zydus hit with trio of FDA observations at Indian injectables plant fkansteiner Thu, 03/10/2022 – 11:02 Source link
.jpg)
